FARO TECHNOLOGIES INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Faro Technologies Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Faro Technologies Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 20.9M shares, a 2.66% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 20.9M +542K +2.66% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 20.8M +458K +2.26% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 20.6M +302K +1.49% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 20.3M +187K +0.93% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 20.3M +175K +0.87% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 20.3M +670K +3.41% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 20.3M +640K +3.26% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 20.2M +568K +2.9% Dec 31, 2022 10-K 2024-02-28
Q3 2022 20.2M +569K +2.9% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 19.7M +94.5K +0.48% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 19.6M +100K +0.51% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 19.6M +204K +1.05% Dec 31, 2021 10-K 2023-02-15
Q3 2021 19.6M +353K +1.84% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 19.6M +389K +2.03% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 19.5M +420K +2.2% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 19.4M +396K +2.09% Dec 31, 2020 10-K 2022-02-16
Q3 2020 19.2M +415K +2.2% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 19.2M +416K +2.22% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 19.1M +441K +2.36% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 19M +312K +1.67% Dec 31, 2019 10-K 2021-02-17
Q3 2019 18.8M +141K +0.76% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 18.8M +312K +1.69% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 18.7M +260K +1.41% Mar 31, 2019 10-Q 2019-10-30
Q4 2018 18.7M +399K +2.18% Dec 31, 2018 10-K 2020-02-19
Q3 2018 18.7M +478K +2.62% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 18.4M +246K +1.35% Jun 30, 2018 10-Q 2018-07-25
Q1 2018 18.4M +238K +1.31% Mar 31, 2018 10-Q 2018-04-25
Q4 2017 18.3M +107K +0.59% Dec 31, 2017 10-K 2019-02-21
Q3 2017 18.2M +33.8K +0.19% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 18.2M +30.9K +0.17% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 18.2M +37.4K +0.21% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 18.2M +92.7K +0.51% Dec 31, 2016 10-K 2018-02-21
Q3 2016 18.2M +86.3K +0.48% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 18.2M +90K +0.5% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 18.1M +83.3K +0.46% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 18.1M +79.9K +0.44% Dec 31, 2015 10-K 2017-02-24
Q3 2015 18.1M +123K +0.68% Sep 26, 2015 10-Q 2015-11-03
Q2 2015 18.1M +146K +0.81% Jun 27, 2015 10-Q 2015-07-29
Q1 2015 18.1M +144K +0.8% Mar 28, 2015 10-Q 2015-04-28
Q4 2014 18M +129K +0.72% Dec 31, 2014 10-K 2016-02-29
Q3 2014 18M +160K +0.9% Sep 27, 2014 10-Q 2014-10-28
Q2 2014 17.9M +139K +0.78% Jun 28, 2014 10-Q 2014-07-29
Q1 2014 17.9M +142K +0.8% Mar 29, 2014 10-Q 2014-04-29
Q4 2013 17.9M +214K +1.22% Dec 31, 2013 10-K 2015-02-25
Q3 2013 17.8M +143K +0.81% Sep 28, 2013 10-Q 2013-10-30
Q2 2013 17.8M +162K +0.92% Jun 29, 2013 10-Q 2013-07-30
Q1 2013 17.8M +170K +0.97% Mar 30, 2013 10-Q 2013-04-30
Q4 2012 17.7M +273K +1.57% Dec 31, 2012 10-K 2014-02-26
Q3 2012 17.7M +345K +1.99% Sep 29, 2012 10-Q 2012-10-31
Q2 2012 17.6M +370K +2.15% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 17.6M +583K +3.42% Mar 31, 2012 10-Q 2012-05-01
Q4 2011 17.4M +487K +2.88% Dec 31, 2011 10-K 2013-02-27
Q3 2011 17.3M Oct 1, 2011 10-Q 2011-11-02
Q2 2011 17.3M Jul 2, 2011 10-Q 2011-08-03
Q1 2011 17M Apr 2, 2011 10-Q 2011-05-06
Q4 2010 16.9M Dec 31, 2010 10-K/A 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.